IN-VITRO IMMUNOCOMPATIBILITY & CHARACTERIZATION AT NANOSCALE OF THIN FILMS AND VASCULAR MEDICAL DEVICES.
- Department of Physics, Laboratory for Thin Films ? Nanosystems and Nanometrology, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece.
- Vascular Surgery Department, First Propaedeutic Surgery Clinic, AHEPA General Hospital, Aristotle University of Thessaloniki, GR-54621, Thessaloniki, Greece.
- Department of Chemistry, Biochemistry Lab, Aristotle University of Thessaloniki, GR-54124, Thessaloniki, Greece.
8 Downloads
98 Views
Abstract
Immunocompatibility comprises a complex response which depends both on the physico-chemical characteristics of the biomaterial and on the hereditary and acquired ability of the recipient to react.
Objective: The objective of the present work was the comparative study of the immunocompatibility of different materials and their morphological characterization.
Methods: The three types of thin films used in this work were the titanium nitride [TiN],Titanium [Ti] and the amorphous hydrogenated diamond-like carbon [a-C:H], which are deposited onto a silicon substrate by Magnetron Sputtering and Plasma-Enhanced Chemical Vapor Deposition (PECVD), respectively. Medical devices used in this study, were the silicon coated Latex irrigation catheter and the endoprosthesis such as vascular grafts [Dacron, PTFE] and stent grafts [Nitinol stent graft, Cobalt Chromium stent graft]. Bare silicon substrate and serum were used as a ?negative? control and the Latex [elastomer-elastic hydrocarbon polymer] as a ?positive? control. Complement C5 convertase [C5c] activation was assessed using the sandwich enzyme immunoassay-sandwich ELISA for the specific time periods [0min, 15 min, 30 min and 60 min] at wavelength of 450nm. The morphological characterization of the materials was conducted by Scanning Electron Microscopy (SEM). The study of biomaterials topography was conducted by Atomic Force Microscopy (AFM) and their surface wettability properties by Contact Angle measurements.
Results: Our results show that both groups of materials (the nanomaterials and the medical devices) are not likely to cause any immunological adverse reaction and as a result might be characterized and selected as excellent candidates for medical applications.
Conclusions: The effectiveness of the study is attributed to the measurement of a single factor in serum in order to acquire important information about the materials? properties e.g immunological response. The possibility to modify the above tested parameters during material synthesis and manufacture could allow limiting their immunological response and improving their immunocompatibility.
Article Analytics
References
- Mastellos D & Lambris JD. Complement:more than a ?guard? against invading pathogens. Trends Immunol 2002;23(10):485-91.
- Loos M. The complement system: activation and control. Curr Top Microbiol Immunol1985;121:7-18
- Mollnes ΤΕ, Song WC & Lambris JD. Complement in inflammatory tissue damage and disease. Trends Immunol 2002;23(2):61-64.
- Rawal N, Pangburn MK. Structure/function of C5convertases of complement. Int Immunopharmacol 2001;1(3):415-
- Moghimi SM, Andersen AJ, Ahmadvand D, Wibroe PP, Andresen AL, Hunter AC. Material properties in complement activation. Adv Drug Deliv Rev 2011;63:1000-1007.
- Andersen AJ, Hashemi AH, Andresen TL, Hunter AC, Moghimi SM. Complement: alive and kicking nanomedicines. J Biomed Nanotechnol 2009;5:364?372.
- Janssen BJ, Christodoulidou A, McCarthy A, Lambris JD, Gros P. Structure of C3b reveals conformational changes that underlie complement activity. Nature 2006;444:213?216.
- Yang D, L? XY, Hong Y, Xi T, Zhang D. The molecular mechanism of mediation of adsorbed serum proteins to endothelial cells adhesion and growth on biomaterials. Biomaterials 2013;34:5747-5758.
- Lord MS, Foss M, Besenbacher F. Influence of nanoscale surface topography on protein adsorption and cellular response. Nano Today 2010;5:66-78.
- Cai K, Bossert J, Jandt KD. Does the nanometre scale topography of titanium influence protein adsorption and cell proliferation? Colloids Surf B 2006;49:136-44.
- Wei JH, Igarashi T, Okumori N, Maetani T, Liu BL, Yoshinari M. Influence of surface wettability on competitive protein adsorption and initial attachment of osteoblasts. Biomed Mater 2009;4:045002.
- Clarke B, Kingshott P, Hou X, Rochev Y, Gorelov A, Carroll W. Effect of nitinol wire surface properties on albumin adsorption. Acta Biomater 2007;3:103-11.
- van Wachem PB, Bengeling T, Feijein J, Bantjes A, Detmers JP, van Aken WG. Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. Biomaterials 1985; 6:403?8.
- Marques AP, Reis RL, Hunt JA. The biocompatibility of novel starch-based polymers and composites: in vitro studies. Biomaterials 2002;23:1471-1478.
- Schulman ES, Post TJ, Henson PM, Giclas PC. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release. J Clin Invest 1988;81:918?23.
- Nataf S, Davoust N, Ames RS, Barnum SR, Human. T cells express the C5a receptor and are chemoattracted to C5a. J Immunol 1999;162:4018?23.
- Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of P selectin in endothelial cells. J Clin Invest 1994;94:1147?55.
- Okusawa S, Yancey KB, van der Meer JW, et al. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med1988;168:443?8.
- Bokisch VA, Muller-Eberhard HJ, Cochrane CG. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum. J Exp Med1969;129:1109?30.
- Speidl WS, Katsaros KM, Kastl SP, Zorn G, Huber K, Maurer G et al. Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a. Atherosclerosis 2010;208:285?289.
- Harboe M, Thorgersen EB, Mollnes TE. Advances in assay of complement function and activation. Adv Drug Deliv Rev 2011;63:976?987.
- Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodriguez CS. Test, Complement analysis in the 21st century. Mol Immunol 2007;44:3838?3849.
- Wagner JL, Hugli TE. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. Anal. Biochem. 1984;136:75?88.
- Oppermann M, Gotze O. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors, Immunology. 1994;82: 516?521.
- Teisner B, Brandslund I, Grunnet N, Hansen LK, Thellesen J, Svehag S.E, Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation. J Clin Lab Immunol1983;12:63?67.
- Mollnes TE. Early- and late-phase activation of complement evaluated by plasma levels of C3d, g and the terminal complement complex. Complement1985;2:156?164.
How to Cite This Article
Milka Janjic, Paraskevi Kavatzikidou, Varvara Karagkiozaki, Theodora Choli-Papadopoulou, Stergios Logothetidis and Kiriakos Ktenidis. (2017); IN-VITRO IMMUNOCOMPATIBILITY & CHARACTERIZATION AT NANOSCALE OF THIN FILMS AND VASCULAR MEDICAL DEVICES., Int. J. of Adv. Res., 5 (10), 1926-1936, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/5720
Corresponding Author
This work is licensed under a Creative Commons Attribution 4.0 International License.





